Zhou Lei, Cai Hongfang
Department of Acupuncture and Moxibustion, Jinhua 321017, Zhejiang Province, China.
Department of Clinical Laboratory, Jinhua Municipal Hospital of TCM, Jinhua 321017, Zhejiang Province, China.
Zhongguo Zhen Jiu. 2018 Apr 12;38(4):349-52. doi: 10.13703/j.0255-2930.2018.04.002.
To observe the effects of acupoint catgut embedding assisting western medication and simple western medication on blood pressure and vascular endothelial function in patients with essential hypertension (EH), and to explore its mechanism.
A total of 125 cases were randomly assigned into an observation group (62 cases, 2 dropping) and a control group (63 cases, 3 dropping). Oral administration of lotensin (10 mg, once a day) was applied in the control group. Based on the treatment as the control group, acupoint catgut embedding was applied at Fengchi (GB 20), Ganshu (BL 18), Shenshu (BL 23), Quchi (LI 11), Zusanli (ST 36), Sanyinjiao (SP 6) and Taichong (LR 3) in the observation group, once every two weeks, and six treatments was taken as one session. All the patients were treated for 3 months. The blood pressure and the vascular endothelial injury markers, including endothelin-1 (ET-1), nitric oxide (NO), high sensitive C reactive protein (hsCRP) were recorded before and after treatment in the two groups. In addition, the ET-1, NO and hsCRP were collected from 60 cases of healthy participants.
The diastolic blood pressure and systolic blood pressure reduced after treatment in the two groups (all <0.05), which were more significant in the observation group (<0.01, <0.05). Before treatment, compared with those of the healthy participants, ET-1 and hsCRP were higher but NO was lower in the observation group and the control group (all <0.05); after treatment, ET-1 and hsCRP were reduced and NO increased in the two groups (all <0.05), which were more significant in the observation group (all <0.05). After treatment, the differences of NO and hsCRP between the observation group and healthy participants were not significant (both >0.05). The marked effective rate was 70.0% (42/60) in the observation group, which was superior to 33.3% (20/60) in the control group (<0.05); the total effective rate was 96.7% (58/60) in the observation group, which was superior to 85.0% (51/60) in the control group (<0.05).
The vascular endothelial function is injured in EH patients. Based on lotensin treatment, acupoint catgut embedding could significantly improve blood pressure and vascular endothelial function.
观察穴位埋线辅助西药与单纯西药治疗对原发性高血压(EH)患者血压及血管内皮功能的影响,并探讨其作用机制。
将125例患者随机分为观察组(62例,脱落2例)和对照组(63例,脱落3例)。对照组口服洛汀新(10 mg,每日1次)。观察组在对照组治疗基础上,于风池(GB 20)、肝俞(BL 18)、肾俞(BL 23)、曲池(LI 11)、足三里(ST 36)、三阴交(SP 6)、太冲(LR 3)穴位进行穴位埋线,每两周1次,6次为1个疗程。所有患者均治疗3个月。记录两组患者治疗前后血压及血管内皮损伤标志物,包括内皮素-1(ET-1)、一氧化氮(NO)、高敏C反应蛋白(hsCRP)。此外,收集60例健康体检者的ET-1、NO及hsCRP。
两组患者治疗后舒张压和收缩压均降低(均P<0.05),观察组更显著(P<0.01,P<0.05)。治疗前,观察组和对照组ET-1、hsCRP高于健康体检者,NO低于健康体检者(均P<0.05);治疗后,两组ET-1、hsCRP降低,NO升高(均P<0.05),观察组更显著(均P<0.05)。治疗后,观察组与健康体检者NO、hsCRP差异无统计学意义(均P>0.05)。观察组显效率为70.0%(42/60),优于对照组的33.3%(20/60)(P<0.05);观察组总有效率为96.7%(58/60),优于对照组的85.0%(51/60)(P<0.05)。
EH患者存在血管内皮功能损伤。在洛汀新治疗基础上,穴位埋线可显著改善血压及血管内皮功能。